Overview

Endothelial Hyperpolarization in Humans

Status:
Terminated
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to elucidate the role Endothelium-Derived Hyperpolarizing Factor (EDHF) plays in dilating blood vessels and whether it differs between healthy people and those with high cholesterol. A second purpose of the study is to determine the identity of EDHF.
Phase:
Phase 2
Details
Lead Sponsor:
Emory University
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Acetylcholine
Bradykinin
Fluconazole
Kininogens
Nitroprusside
omega-N-Methylarginine
Tetraethylammonium